Robert B. Raffa, PhD

Prof Emeritus; Adjunct; CSO: Co-founder; Sci AdBoard
Temple Univ; Univ AZ; Neumentum; Enalare; Advantx
Tucson, Arizona

Presentation(s):

• Poster Number-60 - A Systematic Chemical Design Strategy Leads to NTM-004/005, an Acetaminophen Structural Analog with Minimal Liver Histopathology

  Poster Abstracts

• Poster Number-61 - ADV-484, a Novel Selective Inhibitor of alpha2delta-1 for the Treatment of Neuropathic Pain

  Poster Abstracts

• Poster Number-62 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: I. Discovery and Preclinical Evaluation

  Poster Abstracts

• Poster Number-63 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: II. Tolerance and Opioid-Induced Hyperalgesia

  Poster Abstracts

• Poster Number-64 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: III. Phase-1 Study

  Poster Abstracts

• Poster Number-59 - The Agnostic Respiratory Stimulant ENA-001 Demonstrates Preliminary Positive Results in an Animal Model of Apnea of Prematurity

  Poster Abstracts

• Poster Number-58 - Update on NTM-006, a Novel Orally-Active Non-Opioid Analgesic: Molecular-Modeling Consistent with Allosteric Modulation of the Adenosine A3 Receptor

  Poster Abstracts